NCT01663766 2021-08-19Phase I Study of Milatuzumab for Graft Versus Host DiseaseGilead SciencesPhase 1 Terminated12 enrolled
NCT00421525 2021-08-16Phase I/II Study of hLL1 in Multiple MyelomaGilead SciencesPhase 1/2 Completed25 enrolled